Chemotherapy
Approved for: NSCLC
Necitumumab (Portrazza) is a FDA-approved Chemotherapy for Squamous non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used as first-line treatment.
FDA-Approved Lung Cancer Treatments
Necitumumab (Portrazza)
I want to give in honor of...
name or relation
Donation Amount
other amount